- 9 次围观
产品图片
货号/SKU
NR-52366
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-52366?? Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, Wuhan-Hu-1 with C-Terminal Histidine Tag, Recombinant from HEK293F Cells(Proteins)|SARS-Related Coronavirus 2|Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, Wuhan-Hu-1 with C-Terminal Histidine Tag, Recombinant from HEK293F Cells|-60°C or colder|F Krammer, F Amanat, S StrohmeierAcknowledgment for publications should read “The following reagent was produced under HHSN272201400008C and obtained through BEI Resources, NIAID, NIH: Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, Wuhan-Hu-1 with C-Terminal Histidine Tag, Recombinant from HEK293F Cells, NR-52366.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
A recombinant form of the spike glycoprotein receptor binding domain (RBD) from severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), Wuhan-Hu-1 (GenPept: QHD43416) was produced by transfection of purified plasmid in human embryonic kidney HEK293F cells and purified by nickel affinity chromatography. NR-52366 lacks the signal sequence and contains 223 residues of the SARS-CoV-2 spike glycoprotein RBD and features a C-terminal hexa-histidine tag. NR-52366 has a theoretical molecular weight of 25,900 daltons.
Note: For a detailed protocol and list of related items, see https://labs.icahn.mssm.edu/krammerlab/covid-19/
NR-52366 reacts with monoclonal anti-histidine tag in western blot analysis. NR-52366 is intended for western blot, ELISA and animal vaccination.
Each vial of NR-52366 contains purified recombinant protein in phosphate buffered saline (PBS).
Additional information and tools are available at ViPR (Virus Pathogen Resource).
A recombinant form of the spike glycoprotein receptor binding domain (RBD) from severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), Wuhan-Hu-1 (GenPept: QHD43416) was produced by transfection of purified plasmid in human embryonic kidney HEK293F cells and purified by nickel affinity chromatography. NR-52366 lacks the signal sequence and contains 223 residues of the SARS-CoV-2 spike glycoprotein RBD and features a C-terminal hexa-histidine tag. NR-52366 has a theoretical molecular weight of 25,900 daltons.
Note: For a detailed protocol and list of related items, see https://labs.icahn.mssm.edu/krammerlab/covid-19/
NR-52366 reacts with monoclonal anti-histidine tag in western blot analysis. NR-52366 is intended for western blot, ELISA and animal vaccination.
Each vial of NR-52366 contains purified recombinant protein in phosphate buffered saline (PBS).
Additional information and tools are available at ViPR (Virus Pathogen Resource).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
来自严重急性呼吸综合征相关的冠状病毒2(SARS-COV-2),武汉-U-1(Genpept: QHD43416 ”通过在人胚胎肾HEK293F细胞中转染净化质粒并通过镍亲和层析纯化. NR-52366缺乏信号序列,并含有223个SARS-COV-2穗糖蛋白RBD的残基,并具有C末端六峰组氨酸标签. NR-52366具有理论分子量为25,900道尔顿.
注意:有关相关项的详细协议和列表,请参阅https://labs.icahn.mssm.edu/krammerlab/covid-19/
NR-52366与蛋白质印迹分析中的单克隆抗组氨酸标签反应. NR-52366适用于Western Blot,ELISA和动物疫苗接种.
每个小瓶NR-52366含有磷酸盐缓冲盐水(PBS)的纯化的重组蛋白.
vipr (病毒病原体资源)提供了附加信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-03-31
2022-04-01
2021-12-21
2021-12-13
2021-12-21
2024-05-19
2022-04-01
2024-05-19
2021-12-02
2022-04-01
2024-05-19
2022-04-01
2019-05-08
2021-12-21
2024-06-03